Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Melatonin vs Tranexamic Acid for Melasma
NCT07034560Phase 4Active, not recruiting
- Sponsor
- Thammasat University
- Start
- Nov 2024
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of melatonin in melasma, sponsored by Thammasat University. Started Nov 2024; status: active, not recruiting.
02
Drugs
melatonin
03
Conditions
melasma
Beyond the preview
Go deeper on NCT07034560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07034560.